PHARMA MAR, S.A.
Patent Owner
Stats
- 38 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Nov 28, 2017 most recent publication
Details
- 38 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 938 Total Citation Count
- Sep 09, 1993 Earliest Filing
- 74 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9192568 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseasesOct 30, 06Nov 24, 15[A61K, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0213,000 N-(2-THIAZOLYL)-AMIDE DERIVATIVES FOR THE TREATMENT OF OBESITY, DIABETES AND CARDIOVASCULAR DISEASESAbandonedAug 01, 08Sep 01, 11[A61K, C07D, A61P]
2011/0070,232 Combination Therapy with an Antitumor AlkaloidAbandonedMay 18, 09Mar 24, 11[A61K, A61P]
2010/0267,732 Prognostic Molecular Markers for ET-743 TreatmentAbandonedOct 20, 08Oct 21, 10[A61K, C12Q, A61P]
7772241 Variolin derivatives and their use as antitumor agentsExpiredJan 07, 09Aug 10, 10[A61K, C07D]
7767659 Synthesis of naturally occurring ecteinascidins and related compoundsExpiredFeb 04, 03Aug 03, 10[A61K, A01N, C07D]
7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineeringExpiredDec 19, 03May 25, 10[C12P]
2010/0041,594 Use of Aplidine for the Treatment of Pancreatic CancerAbandonedOct 23, 09Feb 18, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.